Biodesix Q1 EPS $(0.81) Beats $(1.12) Estimate, Sales $25.555M Beat $23.178M Estimate
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.12) by 27.68 percent. This is a 49.38 percent increase over losses of $(1.60) per share from the same
